Educational Session 8: The Illusion of Precision: Therapies without Molecular Selection for Hormone Receptor Positive Metastatic Breast Cancer
Session Details
Moderator
Komal L Jhaveri
Presentation numberED8-01
Current Landscape with Endocrine-Based Treatment in HR+/HER2- MBC
Kevin Kalinsky, Emory Winship Cancer Institute, Atlanta, GA
Presentation numberED8-02
Novel CDK Inhibitors
Timothy A. Yap, University of Texas MD Anderson Cancer Center, Houston, TX
Presentation numberED8-03
Emerging Targeted Approaches in the Treatment of HR Positive MBC
Seth A Wander, Mass General Cancer Center, Boston, MA
Presentation numberED8-04
Contextualizing Approaches to Meet the Needs of the Patient
Kimberly Parekh, University of Massachusetts, Amherst, MA